SCHEDULES

SCHEDULE 2 Controlled Drugs

Part II Class B Drugs

1

The following substances and products, namely:—

F9a

  • Acetyldihydrocodeine.

  • Amphetamine.

  • F12Cannabinol

  • F12Cannabinol derivatives

  • F12Cannabis and cannabis resin

  • F10...

  • Codeine.

  • F1. . .

  • Dihydrocodeine.

  • Ethylmorphine (3-ethylmorphine).

  • F2Glutethimide.

  • F2Lefetamine.

  • F3Mecloqualone.

  • F3Methaqualone.

  • F4Methcathinone

  • F11...

  • F5a-Methylphenethylhydroxylamine

  • Methylphenidate.

  • F3Methylphenobarbitone.

  • Nicocodine.

  • F6Nicodicodine (6-nicotinoyldihydrocodeine).

  • Norcodeine.

  • F7Pentazocine.

  • Phenmetrazine.

  • Pholcodine.

  • F8Propiram.

  • F4Zipeprol

F9b

any 5,5 disubstituted barbituric acid.

F13c

[2,3–Dihydro–5–methyl–3–(4–morpholinylmethyl)pyrrolo[1, 2, 3–de]–1,4–benzoxazin–6–yl]–1–naphthalenylmethanone.

3–Dimethylheptyl–11–hydroxyhexahydrocannabinol.

[9–Hydroxy–6–methyl–3–[5–phenylpentan–2–yl] oxy–5, 6, 6a, 7, 8, 9, 10, 10a–octahydrophenanthridin–1–yl] acetate.

9-(Hydroxymethyl)–6, 6–dimethyl–3–(2–methyloctan–2–yl)–6a, 7, 10, 10a–tetrahydrobenzo[c]chromen–1–ol.

Nabilone.

  • Any compound structurally derived from 3–(1–naphthoyl)indole or 1H–indol–3–yl–(1–naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.

  • Any compound structurally derived from 3–(1–naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent.

  • Any compound structurally derived from 1–(1–naphthylmethyl)indene by substitution at the 3–position of the indene ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.

  • Any compound structurally derived from 3–phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.

  • Any compound structurally derived from 2–(3–hydroxycyclohexyl)phenol by substitution at the 5–position of the phenolic ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the cyclohexyl ring to any extent.